Free Trial

ReposiTrak (NYSE:TRAK) CEO Randall Fields Sells 7,500 Shares

ReposiTrak logo with Computer and Technology background

Key Points

  • Randall Fields, CEO of ReposiTrak, sold 7,500 shares of the company's stock on October 7th, resulting in a 13.04% decrease of his holdings, leaving him with 50,000 shares valued at approximately $748,500.
  • ReposiTrak's stock price recently rose to $15.20, but has seen fluctuations with a 12-month low of $13.86 and a high of $25.01, indicating variability in its market performance.
  • Analysts have recently downgraded ReposiTrak from a "buy" to a "hold" rating, reflecting a cautious outlook on the company's stock moving forward.
  • MarketBeat previews the top five stocks to own by November 1st.

ReposiTrak Inc. (NYSE:TRAK - Get Free Report) CEO Randall Fields sold 7,500 shares of the company's stock in a transaction dated Tuesday, October 7th. The stock was sold at an average price of $14.97, for a total transaction of $112,275.00. Following the sale, the chief executive officer directly owned 50,000 shares of the company's stock, valued at $748,500. This represents a 13.04% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

ReposiTrak Price Performance

TRAK traded up $0.59 on Tuesday, hitting $15.20. 187,673 shares of the stock were exchanged, compared to its average volume of 53,048. ReposiTrak Inc. has a 12 month low of $13.86 and a 12 month high of $25.01. The company has a 50-day moving average of $16.56. The company has a quick ratio of 6.09, a current ratio of 6.09 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $277.86 million, a price-to-earnings ratio of 43.43 and a beta of 0.44.

ReposiTrak (NYSE:TRAK - Get Free Report) last issued its earnings results on Monday, September 29th. The company reported $0.09 EPS for the quarter. ReposiTrak had a return on equity of 14.25% and a net margin of 30.55%.The firm had revenue of $5.76 million during the quarter.

Wall Street Analyst Weigh In

TRAK has been the topic of a number of research analyst reports. Wall Street Zen cut ReposiTrak from a "buy" rating to a "hold" rating in a report on Friday. Weiss Ratings reissued a "hold (c+)" rating on shares of ReposiTrak in a research report on Saturday, September 27th. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, ReposiTrak has a consensus rating of "Hold".

Read Our Latest Analysis on TRAK

Institutional Trading of ReposiTrak

A number of large investors have recently modified their holdings of TRAK. Ashford Capital Management Inc. boosted its position in shares of ReposiTrak by 93.7% during the 2nd quarter. Ashford Capital Management Inc. now owns 792,154 shares of the company's stock valued at $15,566,000 after acquiring an additional 383,283 shares during the last quarter. Handelsbanken Fonder AB raised its holdings in shares of ReposiTrak by 7.1% during the 2nd quarter. Handelsbanken Fonder AB now owns 1,654,348 shares of the company's stock valued at $32,508,000 after buying an additional 110,000 shares in the last quarter. Los Angeles Capital Management LLC purchased a new position in shares of ReposiTrak during the 2nd quarter valued at about $818,000. Jane Street Group LLC purchased a new position in shares of ReposiTrak during the 2nd quarter valued at about $802,000. Finally, Coldstream Capital Management Inc. raised its holdings in shares of ReposiTrak by 47,619.0% during the 2nd quarter. Coldstream Capital Management Inc. now owns 20,042 shares of the company's stock valued at $394,000 after buying an additional 20,000 shares in the last quarter. Institutional investors own 27.35% of the company's stock.

About ReposiTrak

(Get Free Report)

Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.

Read More

Insider Buying and Selling by Quarter for ReposiTrak (NYSE:TRAK)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in ReposiTrak Right Now?

Before you consider ReposiTrak, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ReposiTrak wasn't on the list.

While ReposiTrak currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.